Journal of pharmaceutical and biomedical analysis
Guidance for robustness/ruggedness tests in method validation
Abstract
This paper is intended to give guidance in setting-up and interpreting a robustness test. The different steps in a robustness test are discussed and illustrated with examples. The recommendations given for the different steps are based on approaches found in the literature, several case studies performed by the authors and discussions of the authors within a commission of the French SFSTP (Société Française des Sciences et Techniques Pharmaceutiques). In the end of the paper a worked-out example is given of a robustness test case study set up and interpreted according to the guidelines.
Source and rights
Published by Journal of pharmaceutical and biomedical analysis, 2001. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2001
- Applies to
- 🌐 International
- Country of origin
- 🇧🇪 Belgium
- Scope
- International
- Journal
- Journal of pharmaceutical and biomedical analysis
- PubMed
- 11248467




